Skip to content

Berichrom Heparin

by Behring Diagnostics, Inc. 510(k)

Active United States

510(k) K925200

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK925200 Date28 Jun 1993ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
KFF
Device Class
Class II
Regulation
21 CFR Part 864.7525
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Berichrom Heparin is a chromogenic assay for the quantitative determination of heparin activity in plasma. Classified as an assay device under the nomenclature for Hematology, it measures heparin levels to support the monitoring of anticoagulant therapy.

This device is supplied as a single-use reagent kit and is intended for use in clinical laboratories. It requires no special regulatory conditions beyond its FDA 510(k) clearance (K925200) under product code KFF, with no indication of MRI compatibility or sterility requirements specified. Storage and handling follow standard laboratory protocols for assay reagents.

Other devices from Behring Diagnostics, Inc.

See all devices from Behring Diagnostics, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical purpose does the Berichrom Heparin assay serve in patient care?

    The Berichrom Heparin is designed to measure heparin activity levels in plasma, enabling clinicians to monitor anticoagulant therapy. This helps ensure patients receiving heparin for blood thinning are receiving the correct dosage, reducing the risk of clotting or bleeding complications.

  • Is the Berichrom Heparin kit intended for single-use or repeated use in a laboratory?

    The Berichrom Heparin is explicitly supplied as a single-use reagent kit, meaning each kit is intended for one test cycle only. This aligns with standard laboratory practices for assay reagents to maintain accuracy and prevent cross-contamination.

  • How should the Berichrom Heparin kit be stored, and are there any special handling requirements?

    Storage and handling follow standard laboratory protocols for assay reagents, as no specific sterility or environmental conditions (e.g., refrigeration, temperature ranges) are mentioned in the data. Always refer to the included instructions for the manufacturer’s precise storage guidelines.

  • What regulatory pathway was followed for FDA clearance of the Berichrom Heparin?

    The Berichrom Heparin received FDA 510(k) clearance (K925200) under the Traditional 510(k) review pathway, classified as substantially equivalent to a predicate device. The product code KFF (Hematology) and advisory committee HE (Hematology) confirm its regulatory classification.

  • Does the Berichrom Heparin require any special laboratory setup beyond typical hematology testing?

    No special laboratory setup is implied beyond standard hematology protocols. The device is categorized under Hematology assays and does not mention MRI compatibility, sterility requirements, or additional infrastructure needs, so it integrates into routine plasma analysis workflows.